Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-20-010048
Filing Date
2020-04-29
Accepted
2020-04-29 07:01:48
Documents
2
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-KA form10ka.htm 10-K/A 258109
2 EXHIBIT 31.2 ex31_2.htm EX-31.2 3344
  Complete submission text file 0001140361-20-010048.txt   262570
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34079 | Film No.: 20827311
SIC: 2834 Pharmaceutical Preparations